Capacitive-resistive monopolar radiofrequency
Capacitive-resistive monopolar radiofrequency has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 10, 2026: “Efficacy of nonablative radiofrequency on sexual function in postmenopausal women: a randomized clinical trial”.
1 paper studies it3 findingsUpdated
See all 1 papers on capacitive-resistive monopolar radiofrequency
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“the intervention group showed significantly greater improvements in the Female Sexual Function Index and Vaginal Health Index at post-treatment and at the 12-week follow-up.”
None of its findings points the other way.
- 1 lab in 1 country
- Human trial1
Studies in people
1 study gave capacitive-resistive monopolar radiofrequency to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves Female Sexual Function IndexCohen's d >0.77, 95% CI, 0.25-1.29 up: Improves Vaginal Health Indexd >3.49, 95% CI, 2.68-4.28 no change: Has no effect on vaginal cytology | Randomized trialpost-treatment and 12-week follow-up | WomenPostmenopausal women; genitourinary syndrome of menopause | Menopause (New York, N.Y.), Feb 10, 2026 |
What did studies of capacitive-resistive monopolar radiofrequency find?
3Studies of capacitive-resistive monopolar radiofrequency measured 3 outcomes: vaginal cytology, Vaginal Health Index and Female Sexual Function Index.
Vaginal cytology
no changein humans1
1 study
Vaginal cytology
no changein humans1
Capacitive-resistive monopolar radiofrequency showed no clear effect on vaginal cytology in humans (genitourinary syndrome of menopause).
Human trialgenitourinary syndrome of menopausevaginasix weekly sessionspost-treatment and 12-week follow-upfemales
Vaginal Health Index
upin humans1
1 study
Vaginal Health Index
upin humans1
Capacitive-resistive monopolar radiofrequency improves Vaginal Health Index in humans (genitourinary syndrome of menopause) (d >3.49, 95% CI, 2.68-4.28).
Human trialgenitourinary syndrome of menopausevaginasix weekly sessionspost-treatment and 12-week follow-upfemales
Female Sexual Function Index
upin humans1
1 study
Female Sexual Function Index
upin humans1
Capacitive-resistive monopolar radiofrequency improves Female Sexual Function Index in humans (genitourinary syndrome of menopause) (Cohen's d >0.77, 95% CI, 0.25-1.29).
Human trialgenitourinary syndrome of menopausevaginasix weekly sessionspost-treatment and 12-week follow-upfemales